Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma, Mantle-Cell 14Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Waldenstrom Macroglobulinemia 4Lymphoma, B-Cell 4Lymphoma 4Leukemia, B-Cell 4Leukemia 3Neoplasms 2Melanoma 2Leukemia, Prolymphocytic 2Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Myeloproliferative Disorders 1Lymphoma, AIDS-Related 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphoid 1Leukemia, Hairy Cell 1Hematologic Diseases 1Graft vs Host Disease 1Glioblastoma 1Disease Progression 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Rituximab 3Diphenhydramine 2Bendamustine Hydrochloride 2Acetaminophen 2obinutuzumab 1immunotoxin HA22 1ibrutinib 1fludarabine phosphate 1Vemurafenib 1Valganciclovir 1Therapeutics 1Specimen Handling 1Sodium Chloride 1Polymerase Chain Reaction 1Pentostatin 1Magnetic Resonance Imaging 1Histamine Antagonists 1High-Energy Shock Waves 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Famotidine 1Exercise Test 1Etoposide 1Epinephrine 1Electrocardiography 1Echocardiography 1Dexamethasone 1Cyclophosphamide 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Hairy Cell × ibrutinib × Clear all
NCT01841723 2026-05-13

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
44 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡